Search - tctmd.com

Displaying 41 - 60 of 124

Sort: Relevancy | Date

Presentation THT 2026

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 03, 2026

Presentation THT 2026

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Presenter: Dmitry Yaranov

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Presenter: Brad Williams

March 03, 2026

Presentation THT 2026

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Presenter: Alex Rothman

March 03, 2026

Presentation THT 2026

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Presenter: Ahmad Nusairat

March 03, 2026

Presentation THT 2026

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Presenter: Giora Weisz

March 03, 2026

Presentation THT 2026

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Early Interventions in Heart Failure Medications, Changes in Pulmonary Artery Pressure and Risk of Outcomes in Chronic Heart Failure Patients

Presenter: Sandip K. Zalawadiya

March 03, 2026

Presentation THT 2026

Renal Denervation Beyond HTN: Implications and the Intersection Between Heart Failure and Fatty Liver

Presenter: David E. Kandzari

March 03, 2026

Presentation THT 2026

Contemporary Use of Intra-aortic Balloon Pump in Heart Failure Cardiogenic Shock

Presenter: Naa'irah N. Muhammad

March 03, 2026

Presentation THT 2026

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Presenter: Rami Kahwash

March 03, 2026

Presentation THT 2026

Safety and Feasibility of a Transcatheter Pressure-Driven Implant in Heart Failure (RELIEF-FIH)

Presenter: Alex Rothman

March 03, 2026

Presentation THT 2026

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

Presenter: Stephen Wildhirt

March 03, 2026

Presentation THT 2026

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mark Darkwah

March 03, 2026

Presentation THT 2026

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

Presenter: Neal Patel

March 03, 2026

Presentation THT 2026

Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair

Presenter: Frailyn J. Nunez

March 03, 2026

Presentation THT 2026

Treatment patterns among mixed phenotype transthyretin amyloidosis patients: A real-world multinational survey

Presenter: Mia Papas

March 03, 2026

Advertisement

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Early Interventions in Heart Failure Medications, Changes in Pulmonary Artery Pressure and Risk of Outcomes in Chronic Heart Failure Patients

Renal Denervation Beyond HTN: Implications and the Intersection Between Heart Failure and Fatty Liver

Contemporary Use of Intra-aortic Balloon Pump in Heart Failure Cardiogenic Shock

Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial

Safety and Feasibility of a Transcatheter Pressure-Driven Implant in Heart Failure (RELIEF-FIH)

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair

Treatment patterns among mixed phenotype transthyretin amyloidosis patients: A real-world multinational survey

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content